128 related articles for article (PubMed ID: 1569922)
1. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
Kenakin TP
Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
[TBL] [Abstract][Full Text] [Related]
2. The measurement of antagonist potency and the importance of selective inhibition of agonist uptake processes.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1981 Oct; 219(1):112-20. PubMed ID: 7288599
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between AT(1) and AT(2) angiotensin receptors in rat anococcygeus smooth muscle.
de Godoy MA; de Oliveira AM
J Pharmacol Exp Ther; 2002 Oct; 303(1):333-9. PubMed ID: 12235268
[TBL] [Abstract][Full Text] [Related]
4. The Schild regression in the process of receptor classification.
Kenakin TP
Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
[TBL] [Abstract][Full Text] [Related]
5. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 1. Evidence of involvement of 5-HT2A receptors using functional and radioligand binding assays.
Rogines-Velo MP; Pelorosso FG; Zold CL; Nowak W; Pesce GO; Sardi SP; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):587-95. PubMed ID: 12444501
[TBL] [Abstract][Full Text] [Related]
6. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
Calderone V; Baragatti B; Breschi MC; Martinotti E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
[TBL] [Abstract][Full Text] [Related]
7. Stimulus amplification, efficacy, and the operational model. Part II--ternary complex occupancy mechanisms.
Trzeciakowski JP
J Theor Biol; 1999 Jun; 198(3):347-74. PubMed ID: 10366491
[TBL] [Abstract][Full Text] [Related]
8. Measurement of antagonist affinity for purine receptors of drugs producing concomitant phosphodiesterase blockade: the use of pharmacologic resultant analysis.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1987 Nov; 243(2):482-6. PubMed ID: 2445952
[TBL] [Abstract][Full Text] [Related]
9. Analysis of allosterism in functional assays.
Ehlert FJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):740-54. PubMed ID: 16046613
[TBL] [Abstract][Full Text] [Related]
10. Classification of phenoxybenzamine/prazosin-resistant contractions of rat spleen to norepinephrine by Schild analysis: similarities and differences to postsynaptic alpha-2 adrenoceptors.
Kenakin TP; Novak PJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):206-12. PubMed ID: 2826768
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
Rogines-Velo MP; Pelorosso FG; Zold CL; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
[TBL] [Abstract][Full Text] [Related]
12. Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
Docherty JR; Ruffolo RR
J Pharmacol Exp Ther; 1989 Feb; 248(2):479-83. PubMed ID: 2537400
[TBL] [Abstract][Full Text] [Related]
13. Limitations of Schild plots in a two-receptor system: alpha adrenoceptors of vascular smooth muscle.
Milnor WR
J Pharmacol Exp Ther; 1986 Jul; 238(1):237-41. PubMed ID: 3014117
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors.
Kleckner NW; Dingledine R
Mol Pharmacol; 1989 Sep; 36(3):430-6. PubMed ID: 2550776
[TBL] [Abstract][Full Text] [Related]
16. Why the Schild method is better than Schild realised.
Colquhoun D
Trends Pharmacol Sci; 2007 Dec; 28(12):608-14. PubMed ID: 18023486
[TBL] [Abstract][Full Text] [Related]
17. Antagonist inhibition curves and the measurement of dissociation constants.
Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
[TBL] [Abstract][Full Text] [Related]
18. The effects on Schild regressions of antagonist removal from the receptor compartment by a saturable process.
Kenakin TP; Beek D
Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):103-8. PubMed ID: 3561525
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of an alpha 1A-adrenoceptor mediating contractile responses to noradrenaline in isolated caudal artery of rat.
Lachnit WG; Tran AM; Clarke DE; Ford AP
Br J Pharmacol; 1997 Mar; 120(5):819-26. PubMed ID: 9138687
[TBL] [Abstract][Full Text] [Related]
20. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
Kenakin TP
J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
